Phase 3 Biotech IMUNON Halts Public Offering Plans: What This Means for DNA Immunotherapy Pipeline
Retail Bulls Cheer Imunon’s Pullback From Public Offering, Citing ‘Much Better Funding Options’ By Stocktwits
Imunon (IMNN) Withdraws SEC Registration for Planned Public Offering | IMNN Stock News